LHP588

· Lighthouse Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LHP588, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease [Phase 2]